Deal facts
- Buyer
- Sunstring Ltd
- Target
- A.M.S 2000 Trading Impex SRL
- Deal value
- Not disclosed
- Announced
- 2 January 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- Israel
- Consideration
- Not stated
Sources
Sunstring Ltd has agreed to acquire the assets of A.M.S 2000 Trading Impex SRL, a diagnostics distributor based in Israel, in a transaction structured as an asset sale. The deal was announced on 2 January 2026, following its completion on 31 December 2025. While the specific financial terms of the acquisition remain undisclosed, the transaction represents a significant strategic move within the diagnostics sector. The target operates as a key distributor in the Israeli market, providing essential diagnostic products and services to local healthcare providers.
The transaction has been formally completed, marking the end of the acquisition process. Regulatory approvals were secured prior to the finalisation of the deal, allowing for the immediate transfer of assets and operations. Sunstring Ltd now assumes full ownership of the acquired business assets, integrating them into its existing portfolio. This acquisition strengthens the buyer's market position in the region without requiring a full corporate merger. The parties have confirmed that all necessary legal and administrative requirements have been satisfied to finalise the sale.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Sunstring Ltd to acquire A.M.S 2000 Trading Impex SRL
{ "headline": "Completion of Sale of Diagnostics Distributor", "issuer": "BATM Advanced Communications Ltd. (BVC)", "announcement_date": "2026-01-02T07:00:00", "category_code": "Class 2 Disposal", "body": "Disclaimer* \n\n LEI: 213800FLQUB9J289RU66 \n\n 2 January 2026 \n\n \n\n BATM Advanced Communications Limited \n\n (\"BATM\" or \"the Group\") \n\n \n\n Completion of Sale of Di
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
COMREF Chiron IRF, LLC to acquire Chiron Real Estate Inc.
COMREF Chiron IRF, LLC has agreed to acquire Chiron Real Estate Inc. in an asset sale valued at USD 217 million. The transaction, which involves cash consideration only,…
- Buyer
- COMREF Chiron IRF, LLC
- Target
- Chiron Real Estate Inc.
- Deal value
- USD 217,000,000
- Deal type
- asset sale
Nuvo Pharmaceuticals (Ireland) DAC to acquire Cumberland Pharmaceuticals Inc.
Nuvo Pharmaceuticals (Ireland) DAC has agreed to acquire the assets of Cumberland Pharmaceuticals Inc. in a cash transaction valued at USD 100 million. The deal, classif…
- Buyer
- Nuvo Pharmaceuticals (Ireland) DAC
- Target
- Cumberland Pharmaceuticals Inc.
- Deal value
- USD 100,000,000
- Deal type
- asset sale
Milton Chen to acquire VSee Lab, Inc.
Milton Chen has agreed to acquire the assets of VSee Lab, Inc. in a management buyout structure. The transaction involves consideration in the form of shares, with the d…
- Buyer
- Milton Chen
- Target
- VSee Lab, Inc.
- Deal value
- Not disclosed
- Deal type
- asset sale
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC to acquire Selectis Health, Inc.
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC and Selectis Health, Inc. entered the Exit Mode archive.
- Buyer
- GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC
- Target
- Selectis Health, Inc.
- Deal value
- USD 15,700,000
- Deal type
- asset sale
MeiraGTx Holdings plc to acquire Janssen Pharmaceuticals, Inc.
MeiraGTx Holdings plc and Janssen Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- MeiraGTx Holdings plc
- Target
- Janssen Pharmaceuticals, Inc.
- Deal value
- USD 25,000,000
- Deal type
- asset sale
Buyer history
Sunstring Ltd
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive
